Buy 7 Largecap Healthcare Stocks For Upto 36% Potential Upside: Motilal Oswal Recommends

Healthcare stocks have given significant returns to investors from the Covid-Pandemic. Here 5 top healthcare stocks have been discussed, brokerage firm Motilal Oswal has given buy rating to these 7 large-cap / bluechip stocks; check stock performances on NSE. The Current Market Price (CMP) of Dr Reddys Lab is Rs. 4082. Motilal Oswal has estimated a Target Price for the stock at Rs. 5000. This stock has the potential to give 22% return, in the upcoming 1 year. In the past 6 months it has gained 2.53%, but in last 1 year its share price has fallen by 14.01%. Its 52-week high range is Rs. 5,077, and 52-week low range is Rs. 3,654. It is a large-cap stock with a market capitalization of around Rs. 68,229 crore.Advertisement The Current Market Price (CMP) of Sun Pharma is Rs. 869. Motilal Oswal has estimated a Target Price for the stock at Rs. 1100. This stock has the potential to give 27% return, in the upcoming 1 year. In the past 6 months it has fallen 4.42%, but in last 1 year its share price has gained by 15.46%. Its 52-week high range is Rs. 967.05, and 52-week low range is Rs. 733.70. It is a large-cap stock with a market capitalization of around Rs. 209,905 crore. The Current Market Price (CMP) of Aurobindo is Rs. 534. Motilal Oswal has estimated a Target Price for the stock at Rs. 690. This stock has the potential to give 29% return, in the upcoming 1 year. In the past 6 months it has fallen 23.61%, and in last 1 year its share price has fallen by 27.15%. Its 52-week high range is Rs. 751.90, and 52-week low range is Rs. 503.45. It is a large-cap stock with a market capitalization of around Rs. 30,439 crore. The Current Market Price (CMP) of Divis Lab is Rs. 3574. Motilal Oswal has estimated a Target Price for the stock at Rs. 4340. This stock has the potential to give 21% return, in the upcoming 1 year. In the past 6 months it has fallen 18.73%, and in last 1 year its share price has fallen by 29.13%. Its 52-week high range is Rs. 5,425.10, and 52-week low range is Rs. 3,365.55. It is a large-cap stock with a market capitalization of around Rs. 96,087 crore. The Current Market Price (CMP) of IPCA Labs is Rs. 863. Motilal Oswal has estimated a Target Price for the stock at Rs. 1170. This stock has the potential to give 36% return, in the upcoming 1 year. In the past 6 months it has fallen 14.46%, and in last 1 year its share price has fallen by 28.85%. Its 52-week high range is Rs. 4,072, and 52-week low range is Rs. 2,180. It is a large-cap stock with a market capitalization of around Rs. 21,779 crore. The Current Market Price (CMP) of Gland Pharma is Rs. 2293. Motilal Oswal has estimated a Target Price for the stock at Rs. 3000. This stock has the potential to give 31% return, in the upcoming 1 year. In the past 6 months it has fallen 31.46%, and in last 1 year its share price has fallen by 42.31%. Its 52-week high range is Rs. 4,072, and 52-week low range is Rs. 2,180. It is a large-cap stock with a market capitalization of around Rs. 37,003 crore. The Current Market Price (CMP) of Laurus Labs is Rs. 517. Motilal Oswal has estimated a Target Price for the stock at Rs. 680. This stock has the potential to give 32% return, in the upcoming 1 year. In the past 6 months it has fallen 14.17%, and in last 1 year its share price has fallen by 19.68%. Its 52-week high range is Rs. 663, and 52-week low range is Rs. 436.80. It is a large-cap stock with a market capitalization of around Rs. 27,268 crore. The above stock was picked from the brokerage report of Motilal Oswal. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.